Lilly puts $700M into genetic medicine institute
Bio Pharma Dive
FEBRUARY 22, 2022
Building on Lilly's acquisition of Prevail Therapeutics, the Boston-based facility will use RNA- and DNA-based technologies to develop new drugs, while also supporting biotech startups in the area
Let's personalize your content